||
心肌炎是接受免疫检查点抑制剂治疗的癌症患者可能发生的并发症。尽管不良事件很罕见——只有不到1%的接受免疫治疗的患者受到影响——但死亡率接近50%。现在,范德比尔特-英格拉姆癌症中心的研究人员已经确定了这种致命心脏炎症的机制。https://www.ebiotrade.com/newsf/2022-11/20221117004206532.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=2a2184f0-4b04-4436-828c-886b80153d86
01. | 2022 | 7 篇 | 20.588% |
02. | 2021 | 4 篇 | 11.765% |
03. | 2020 | 11 篇 | 32.353% |
04. | 2019 | 4 篇 | 11.765% |
05. | 2018 | 1 篇 | 2.941% |
06. | 2017 | 1 篇 | 2.941% |
07. | 2014 | 1 篇 | 2.941% |
08. | 2007 | 1 篇 | 2.941% |
09. | 2000 | 1 篇 | 2.941% |
10. | 1997 | 1 篇 | 2.941% |
01. | adv exp med biol | 3 篇 | 8.824% |
02. | j immunother cancer | 3 篇 | 8.824% |
03. | circulation | 2 篇 | 5.882% |
04. | front immunol | 2 篇 | 5.882% |
05. | front pharmacol | 2 篇 | 5.882% |
06. | sci rep | 2 篇 | 5.882% |
07. | am heart j | 1 篇 | 2.941% |
08. | anatol j cardiol | 1 篇 | 2.941% |
09. | cancers (basel) | 1 篇 | 2.941% |
10. | cardiovasc res | 1 篇 | 2.941% |
01. | 美国 | 18 篇 | 52.941% |
02. | 中国 | 5 篇 | 14.706% |
03. | 德国 | 5 篇 | 14.706% |
04. | 法国 | 5 篇 | 14.706% |
05. | 西班牙 | 4 篇 | 11.765% |
06. | 英国 | 3 篇 | 8.824% |
07. | 瑞士 | 2 篇 | 5.882% |
08. | 加拿大 | 1 篇 | 2.941% |
09. | 土耳其 | 1 篇 | 2.941% |
10. | 以色列 | 1 篇 | 2.941% |
01. | 中国北京 | 2 篇 | 5.882% |
02. | 中国武汉 | 1 篇 | 2.941% |
03. | 中国广州 | 1 篇 | 2.941% |
01. | Humans | 24 篇 | 70.588% |
02. | Myocarditis | 16 篇 | 47.059% |
03. | Male | 13 篇 | 38.235% |
04. | Animals | 10 篇 | 29.412% |
05. | Immune Checkpoint Inhibitors | 10 篇 | 29.412% |
06. | Neoplasms | 9 篇 | 26.471% |
07. | Female | 8 篇 | 23.529% |
08. | Mice | 7 篇 | 20.588% |
09. | Adult | 6 篇 | 17.647% |
10. | Cardiotoxicity | 5 篇 | 14.706% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-9-2 17:22
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社